Results 201 to 210 of about 731,846 (342)

Prognosis and treatment response stratification according to loss of proofreading (LOP) <i>POLE</i> variants. [PDF]

open access: yesJ Immunother Cancer
Maddalena G   +11 more
europepmc   +1 more source

The Vegan Villain Sets Out to The End of Summer: Functionalized Coatings as Biohybrid UV‐Sensors

open access: yesAdvanced Materials Interfaces, EarlyView.
This study introduces biohybrid coatings incorporating E. coli biomass expressing photoconvertible fluorescent proteins as UV‐A responsive elements. Upon irradiation at 400 nm, the coatings exhibit an irreversible fluorescence shift from green to red within 15 min. Notably, the photoconversion capability is retained after >1 year of storage.
Amelie Skopp   +3 more
wiley   +1 more source

Sp alpha I/78: a mutation of the alpha I spectrin domain in a white kindred with HE and HPP phenotypes [PDF]

open access: bronze, 1989
MC Lecomte   +9 more
openalex   +1 more source

Phenotypic effects of a fertility mutation in Norwgain White Sheep

open access: yes, 2013
Norwegian White Sheep (NWS) is a synthetic breed that results from crosses between local Norwegian and foreign breeds. This breed is mainly kept for the meat production, and litter size is therefore a trait of large economic value. A mutation in the ovine GDF9 gene (c.1111G>A) on chromosome 5 was recently found to be associated with increased litter ...
openaire   +1 more source

Biogenic Next‐Gen CPL Emitters: Strategies with Proteins, Polysaccharides, and Nucleotides

open access: yesAdvanced Optical Materials, EarlyView.
Biogenic molecules such as proteins, peptides, saccharides, and DNA can act as natural scaffolds for generating circularly polarized luminescence (CPL). This review highlights recent strategies exploiting these inherently chiral frameworks to achieve light emission with controllable handedness under unpolarized excitation, bridging biological ...
Ricardo Chavez‐Jimenez   +4 more
wiley   +1 more source

Structural Characterization and AI‐Enhanced Modeling of a Broadly Neutralizing Camelid Antibody Against SARS‐CoV‐2 Variants

open access: yesAdvanced Therapeutics, EarlyView.
This study characterizes a camelid antibody (B10) with potent neutralizing activity against SARS‐CoV‐2 Wildtype and Omicron variants. Through binding assays, epitope mapping, pseudovirus neutralization, and AI‐driven modeling, the antibody is shown to target conserved RBD regions in a closed Spike conformation.
Katja Hanack   +13 more
wiley   +1 more source

MMP2‐Responsive Liposomes Targeting LDLR Enhance the Effectiveness of Anti‐Cancer Drugs in Treating Melanoma

open access: yesAdvanced Therapeutics, EarlyView.
A bi‐functional liposomal system is developed to enhance melanoma therapy, combining mApoE‐mediated targeting of LDLR‐expressing tumor cells with MMP2‐responsive drug release. Loaded with Pimasertib, the liposomes improve intracellular delivery, reduce melanoma viability, and inhibit 3D spheroid growth and invasiveness.
Antonio Renda   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy